Gene therapies can correct diseases at their genetic core, but their success hinges on viral vector manufacturing. As gene therapy technology becomes more advanced, producing viral vectors becomes ...
GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila, has received the Emergency Use Authorization ...
As a lab within the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutch, the Vector Production core assists investigators with the design, construction, and/or production of viral ...
ProteoNic Biosciences partnered with Ginkgo Bioworks (NYSE:DNA), the alliance will grant Ginkgo Bioworks' (DNA) customers access to ProteoNic's vector technology in the field of protein production and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback